(Q36091591)

12 August 2017

1 reference

title

Endocrine disturbances in depression (English)

1 reference

12 August 2017

Tichomirowa MA

1

1 reference

12 August 2017

Keck ME

2

1 reference

12 August 2017

Schneider HJ

3

1 reference

12 August 2017

Paez-Pereda M

4

1 reference

12 August 2017

Renner U

5

1 reference

12 August 2017

Holsboer F

6

1 reference

12 August 2017

Stalla GK

7

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Journal of Endocrinological Investigation

12 August 2017

published in

1 reference

12 August 2017

volume

28

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

89-99

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Thyroid hormones in depressive disorders: a reappraisal of clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Psychoneuroendocrinology of depression. Growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The hypothalamic-pituitary-gonadal axis in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Vasopressin as a target for antidepressant development: an assessment of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: evidence for increased ACTH pulse frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Pituitary size in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Adrenal gland enlargement in major depression. A computed tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The role of corticotropin-releasing factor in depression and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Genetic modification of corticosteroid receptor signalling: novel insights into pathophysiology and treatment strategies of human affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Corticotrophin-releasing factor receptors: from molecular biology to drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Characterization of corticotropin-releasing factor receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The impact of physiological stimuli on the expression of corticotropin-releasing hormone (CRH) and other neuropeptide genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Plasma levels of arginine vasopressin elevated in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Growth hormone secretion during sleep in male depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Effect of clonidine on growth hormone release in psychiatric patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Growth hormone secretion in children and adolescents at high risk for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Relationship between pituitary responses to human corticotropin-releasing factor and thyrotropin-releasing hormone in depressives and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Thyroid function in clinical subtypes of major depression: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Sex Differences and the Epidemiology of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Women and mood disorders. Menarche to menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Immunocytochemical evidence for direct synaptic connections between corticotrophin-releasing factor (CRF) and gonadotrophin-releasing hormone (GnRH)-containing neurons in the preoptic area of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Dehydroepiandrosterone (DHEA) treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Regulation of appetite and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Plasma leptin in depressed patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Elevated nocturnal profiles of serum leptin in patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Low leptin levels but normal body mass indices in patients with depression or schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Influence of Human Corticotropin-Releasing Hormone and Adrenocorticotropin upon Spontaneous Growth Hormone Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345535

Double-blind treatment of major depression with dehydroepiandrosterone

21 January 2018

1 reference

12 December 2020

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

1 reference

12 December 2020

Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication

1 reference

12 December 2020

Neuroendocrine aspects of primary endogenous depression. X: Serum growth hormone measures in patients and matched control subjects

1 reference

12 December 2020

Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion

1 reference

12 December 2020

Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients

1 reference

12 December 2020

Neurosteroids in depression: a review

1 reference

12 December 2020

Corticotropin-releasing hormone modulators and depression

1 reference

12 December 2020

Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress

1 reference

12 December 2020

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

1 reference

12 December 2020

Glucocorticoid receptor-mediated repression of gonadotropin-releasing hormone promoter activity in GT1 hypothalamic cell lines

1 reference

12 December 2020

Plasticity and function of brain corticosteroid receptors during aging

1 reference

12 December 2020

Insulin-like growth factor I in depressed patients and controls

1 reference

12 December 2020

Elevated corticosteroids as a possible cause of abnormal neuroendocrine function in depressive illness

1 reference

12 December 2020

Antidepressants and hypothalamic-pituitary-adrenocortical regulation

1 reference

12 December 2020

Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls

1 reference

12 December 2020

Low growth hormone response to growth hormone-releasing hormone in child depression

1 reference

12 December 2020

The GH response to clonidine in endogenous as compared with reactive depression

1 reference

12 December 2020

Association of depression with reduced heart rate variability in coronary artery disease

1 reference

12 December 2020

Multihormonal responses to clonidine in patients with affective and psychotic symptoms

1 reference

12 December 2020

An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial

1 reference

12 December 2020

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

12 December 2020

Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man

1 reference

12 December 2020

Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test

1 reference

12 December 2020

CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients

1 reference

12 December 2020

Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives

1 reference

12 December 2020

Cerebrospinal fluid somatostatin and psychiatric illness

1 reference

12 December 2020

Human corticotropin-releasing hormone in depression--correlation with thyrotropin secretion following thyrotropin-releasing hormone

1 reference

12 December 2020

Testosterone, gonadotropin, and cortisol secretion in male patients with major depression

1 reference

12 December 2020

Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity

1 reference

12 December 2020

Adrenal androgens and cortisol in major depression

1 reference

12 December 2020

Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

1 reference

12 December 2020

Glucocorticoid repression of gonadotropin-releasing hormone gene expression and secretion in morphologically distinct subpopulations of GT1-7 cells

1 reference

12 December 2020

Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain

1 reference

12 December 2020

Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress

1 reference

12 December 2020

[Leptin and psychiatric disorders]

1 reference

12 December 2020

Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication

1 reference

12 December 2020

Psychoneuroendocrine research in depression

1 reference

12 December 2020

Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345535

1 reference

12 August 2017

1 reference